Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Clear-cell metastatic renal cell carcinoma × Axitinib × Clear all

Phase

Status

Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Endometrial Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Clear-cell metastatic renal cell carcinoma 1

Interventions

cabozantinib 2 pembrolizumab 1 lenvatinib 1 fludarabine 1 Selenomethionine 1 Nivolumab 1 Ipilimumab 1 Everolimus 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05363631 2025-12-10

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

University of Iowa

Phase 1/2 Active not recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡